:,rituximabHBV

Anna A Nowicka1,2,3, Anna Szymanek-Pasternak1,2, Justyna Janocha-Litwin1,2,4

  • 1Clinical Department of Infectious Diseases and Hepatology, Wroclaw Medical University, Wroclaw, Poland.

概括

晚期乙型肝炎病毒 (HBV) 再激活即使在推的预防和监测后也可能发生. 这一案例凸显了对接受免疫抑制治疗的患者需要扩大警和标准化方案的需要.